BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haqqi A, Munir R, Khalid M, Khurram M, Zaid M, Ali M, Shah ZH, Ahmed H, Afzal MS. Prevalence of Hepatitis C Virus Genotypes in Pakistan: Current Scenario and Review of Literature. Viral Immunol 2019;32:402-13. [PMID: 31556811 DOI: 10.1089/vim.2019.0058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Riaz S, Tiwana H, Adil M, Ali K, Javed T. Anti-hepatitis C virus and synergistic potential of Syzgium cumine a bioassay guided screening in liver-infected hepatocytes. Arch Microbiol 2022;204. [DOI: 10.1007/s00203-021-02646-3] [Reference Citation Analysis]
2 Qasim SF, Jami A, Imran P, Mushtaque R, Khan RN. Frequency of Metabolic Syndrome in Chronic Hepatitis C Patients: Findings From a Lower Middle Income Country. Cureus 2020;12:e11975. [PMID: 33425547 DOI: 10.7759/cureus.11975] [Reference Citation Analysis]
3 Noreen A, Alam N, Syed Z, Aftab A, Shamim F, Najeebullah S, Khan D, Kakar SJ, Ahmed T, Adnan F. Prevalence and assessment of the associated risk factors of hepatitis B and C infections in the low socioeconomic communities. Future Virology. [DOI: 10.2217/fvl-2021-0060] [Reference Citation Analysis]
4 Hussain N, Bungau S, Behl T, Sehgal A, Mahmood M, Manzoor S, Qayyum MA, Khan MI, Moleriu LC, Bilal M. Distribution of hepatitis C virus genotypes in Punjab region, Pakistan, based on a study of 4177 specimens. Infect Genet Evol 2021;91:104811. [PMID: 33741510 DOI: 10.1016/j.meegid.2021.104811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yousaf A, Ghafoor A, Fatima N, Danish M. Gender-Specific Frequency Distribution of Hepatitis C Virus Genotypes in Punjab province, Pakistan: A Clinically Significant Descriptive Cross-Sectional Study. Cureus 2021;13:e17480. [PMID: 34589367 DOI: 10.7759/cureus.17480] [Reference Citation Analysis]
6 Manzoor S, Khalil S, Malik MA, Shafique K, Gul S, Javed F. Induction of Profibrotic Microenvironment via TLR4 MyD88-Dependent and -Independent Inflammatory Signaling in Chronic Hepatitis C Virus Infection. Viral Immunol 2020;33:585-93. [PMID: 32808884 DOI: 10.1089/vim.2019.0175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Shah I, Ahmad W, Qadir A, Muhammad I, Islam M, Shah M, Jan N, Anjum S. Efficacy and Safety of Sofosbuvir and Velpatasvir Combination for the Treatment of Chronic Hepatitis C in Patients With or Without Cirrhosis. Cureus 2021;13:e19768. [PMID: 34950547 DOI: 10.7759/cureus.19768] [Reference Citation Analysis]
8 Marascio N, Mazzitelli M, Scarlata GG, Giancotti A, Barreca GS, Lamberti AG, Divenuto F, Costa C, Trecarichi EM, Matera G, Liberto MC, Torti C. HCV Antibody Prevalence and Genotype Evolution in a Teaching Hospital, Calabria Region, Southern Italy Over A Decade (2008-2018). TOMICROJ 2020;14:84-90. [DOI: 10.2174/1874285802014010084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rashid M, Ismail H. HCV extinction analysis in district Gujrat, Pakistan by using SARIMA and linear regression models. Medicine (Baltimore) 2021;100:e28193. [PMID: 34889300 DOI: 10.1097/MD.0000000000028193] [Reference Citation Analysis]